Dallas, TX -- (SBWIRE) -- 02/23/2012 -- These devices can be used to treat either coronary arterial or peripheral arterial disease (PAD), but only those devices used for peripheral procedures are included in this report. Older individuals and those who are obese have a higher risk of developing PAD. As result of a general increase in peripheral procedures and the development of new lower limb treatments, the market for devices such as chronic total occlusion (CTO) devices will grow rapidly in the U.S. over the forecast period.
Within the U.S. peripheral vascular market, companies such as Boston Scientific, Cordis, Cook Medical, C.R. Bard and W.L. Gore lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
By 2018, the U.S. market for peripheral vascular devices will surpass $7.1 billion. The peripheral vascular device market includes:
- Percutaneous transluminal angioplasty (PTA) balloon catheters
- Atherectomy devices
- Chronic total occlusion devices
- Stent grafts
- Surgical grafts
- Arteriovenous (AV) access thrombectomy devices
- Inferior vena cava filters
- Introducer sheaths
- Vascular closure devices
- Transcatheter embolization devices
Request A Sample, Read Comprehensive Table of Contents and more @ http://www.reportsnreports.com/reports/148901-us-market-for-peripheral-vascular-devices-2012.html. Contact email@example.com for further information.
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)